Novartis Sues Viatris, Others In New IP Fight Over Heart Drug

By Jasmin Jackson (October 25, 2022, 5:34 PM EDT) -- Amid Novartis' ongoing multidistrict patent litigation against generic-drug makers over the heart medication Entresto, the Swiss pharmaceutical giant has now targeted Viatris and others in a new Delaware federal court infringement suit over another Entresto patent....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!